Epidemiology of Helicobacter pylori infection;Epidemiologie Helicobacter pylori

Vnitrni Lekarstvi

Volumn 57, Issue 12, 2011, Pages 993-999

  Bureš, Jan ^a,b   Kopacova M ^a   Skodova Fendrichova M ^a   Rejchrt, S ^a  

^a UK v Hradci Králové ^*  (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Epidemiology; Helicobacter pylori infection

Indexed keywords

ARTICLE; CHILDHOOD; CROWDING; DENSITY; DEVELOPING COUNTRY; HELICOBACTER INFECTION; HOUSING; HUMAN; INFECTION RISK; PREVALENCE; SOCIAL STATUS;

CZECH REPUBLIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PREVALENCE; RISK FACTORS;

EID: 84855613201     PISSN: 0042773X     EISSN: 18017592     Source Type: Journal    
DOI: None     Document Type: Article

References (102)

1. Goodwin CS. Helicobacter pylori: 10th anniversary of its culture in April 1982. Gut 1993; 34: 293-294. (Pubitemid 23080249)
2. Bureš J, Burešová E, Rejchrt S. Imunologické aspekty infekce Helicobacter pylori. Acta Medica (Hradec Králové) 2002; 45: 3-10.
3. Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 321: 1273.
4. Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 321: 1273-1275.
5. Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999; 179: 1523-1530. (Pubitemid 29246603)
6. Linz B, Balloux F, Moodley Y et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007; 445: 915-918.
7. Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007; 21: 205-214. (Pubitemid 46421909)
8. Bruce MG, Maaroos HI. Epidemiology of Helicobacter pylori infection. Helicobacter 2008; 13 (Suppl 1): 1-6.
9. Bureš J. Helicobacter pylori a nesteroidní antiflogistika. In: J Špičák et al. Novinky v gastroenterologii a hepatologii. 1. vyd. Praha: Grada Publishing, 2008: 119-149.
10. Azevedo NF, Huntington J, Goodman KJ. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2009; 14 (Suppl 1): 1-7.
11. Ford AC, Axon ATR. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2010; 15 (Suppl 1): 1-6.
12. Goh KL, Chan WK, Shiota S et al. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2011; 16 (Suppl 1): 1-9.
13. Crowe SE. Bacteriology and epidemiology of Helicobacter pylori infection. UpToDate on line 19. 2. Wellesley, 2011. Available at: http://www.uptodate.com/ contents/bacteriology-and-epidemiology-of-helicobacter-pylori-infection.
14. Meyer B, Werth B, Beglinger C et al. Helicobacter pylori infection in healthy people: a dynamic process? Gut 1991; 32: 347-350.
15. Working Party of the European Helicobacter pylori Study Group. Statistical annex: statistical aspects of clinical trials in Helicobacter pylori infection. Gut 1997; 41 (Suppl 2): S19-S23.
16. Working Party of the European Helicobacter pylori Study Group. Technical annex: tests used to assess Helicobacter pylori infection. Gut 1997; 41 (Suppl 2): S10-S18.
17. Cockburn M, Cox B. The effect of measurement error on the determination of Helicobacter pylori prevalence. Epidemiology 1997; 8: 205-209. (Pubitemid 27084195)
18. Malfertheiner P, Mégraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-180. (Pubitemid 34146357)
19. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781. (Pubitemid 46854190)
20. Weck MN, Brenner H. Apparent incidence of Helicobacter pylori in adulthood: to what extent do new infections reflect misclassification? Helicobacter 2011; 16: 266-275.
21. Bureš J, Kopáčová M, Koupil I et al. Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter 2006; 11: 56-65.
22. Sýkora J, Siala K, Varvarovská J et al. Epidemiology of Helicobacter pylori infection in asymptomatic children: a prospective population-based study from the Czech Republic. Application of a monoclonalbased antigen-in-stool enzyme immunoassay. Helicobacter 2009; 14: 286-297.
23. Blecker U, Hauser B, Lanciers S et al. The prevalence of Helicobacter pylori-positive serology in asymptomatic children. J Pediatr Gastroenterol Nutr 1993; 16: 252-256. (Pubitemid 23127645)
24. Blecker U, Lanciers S, Hauser B et al. Helicobacter pylori positivity in Belgium. Acta Gastroenterol Belg 1995; 58: 31-34.
25. Boltshauser S, Herzog D. Prevalence of Helicobacter pylori infection in asymptomatic 5-7-year-old children of St. Gallen canton. Schweiz Med Wschr 1999; 129: 579-584. (Pubitemid 29200135)
26. Blecker U, Lanciers S, Hauser B et al. Serology as a valid screening test for Helicobacter pylori infection in asymptomatic subjects. Arch Pathol Lab Med 1995; 119: 30-32.
27. De Schryver AA, Van Hooste WL, Van Winckel MA et al. Helicobacter pylori infection: a global occupational risk for healthcare workers? Int J Occup Environ Health 2004; 10: 428-432. (Pubitemid 40292364)
28. Blecker SI, Smalligan RD, Frame JD et al. Risk of Helicobacter pylori infection among long-term residents in developing countries. Am J Trop Med Hyg 1999; 60: 267-270. (Pubitemid 29107115)
29. Holcombe C, Otomara BA, Eldridge J et al. H. pylori, the most common bacterial infection in Africa: a random serological study. Am J Gastroenterol 1992; 87: 28-30.
30. Fox JG, Wang TC, Nagler-Anderson C. The African enigma: the parasite's perspective. Gut 2001; 49: 156-157.
31. Agha A, Graham DY. Evidence-based examination of the African enigma in relation to Helicobacter pylori infection. Scand J Gastroenterol 2005; 40: 523-529. (Pubitemid 40676245)
32. Graham DY, Lu H, Yamaoka Y. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis 2009; 10: 77-84.
33. Kopáčová M, Bureš J, Koupilová I et al. Prevalence of Helicobacter pylori infection in non-selected general population in Czech republic. No birth-cohort phenomenon found in multicentre prospective study. Gut 2002; 51 (Suppl 3): A108.
34. den Hoed CM, Vila AJ, Holster IL et al. Helicobacter pylori and the birth cohort effect: evidence for stabilized colonization rates in childhood. Helicobacter 2011; 16: 405-409.
35. Sýkora J, Rowland M. Helicobacter pylori in pediatrics. Helicobacter 2011; 16 (Suppl 1): 59-64.
36. De Francesco V, Giorgio F, Hassan C et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointest Liver Dis 2010; 19: 409-414.
37. Kopáčová M, Bureš J. Sekvenční léčba Helicobacter pylori. Folia Gastroenterol Hepatol 2009; 7: 82-84.
38. Mbulaiteye SM, Hisada M, El-Omar EM. Helicobacter pylori associated global gastric cancer burden. Front Biosci 2009; 14: 1490-1504.
39. Malfetheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet 2009; 374: 1449-1461.
40. Martinek J, Benes M, Brandtl P et al. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study. Endoscopy 2008; 40: 711-716.
41. Seifert B, Rubin G, de Wit N et al. The management of common gastrointestinal disorders in general practice A survey by the European Society for Primary Care Gastroenterology (ESPCG) in six European countries. Dig Liver Dis 2008; 40: 659-666.
42. Blaser MJ. Helicobacter pylori and esophageal disease: wake-up call? Gastroenterology 2010; 139: 1819-1822.
43. Dítě P, Geryk E. Trends of primary and subsequent cancers of the gastrointestinal tract in the Czech population, 1976-2005. Dig Dis 2010; 28: 657-669.
44. McJunkin B, Sissoko M, Levien J et al. Dramatic decline in prevalence of Helicobacter pylori and peptic ulcer disease in an endoscopy-referral population. Am J Med 2011; 124: 260-264.
45. Pandolfino JE, Kahrilas PJ. Helicobacter pylori and gastroesophageal reflux disease. UpToDate on line 19. 2. Wellesley, 2011. http://www.uptodate. com/contents/helicobacter-pylori-and-gastroesophageal-reflux-disease.
46. Moyaert H, Franceschi F, Roccarina D et al. Extragastric manifestations of Helicobacter pylori infection: other Helicobacters. Helicobacter 2008; 13 (Suppl 1): 47-57.
47. Pellicano R, Franceschi F, Saracco G et al. Helicobacters and extragastric diseases. Helicobacter 2009; 14 (Suppl 1): 58-68.
48. Figura N, Franceschi F, Santucci A et al. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2010; 15 (Suppl 1): 60-68.
49. Suzuki H, Franceschi F, Nishizawa T et al. Extragastric Manifestations of Helicobacter pylori Infection. Helicobacter 2011; 16 (Suppl 1): 65-69.
50. 13C: metodika vyšetření. Čas Lék Čes 2000; 139: 776-778.
51. 13C-urea breath test for the diagnosis of Helicobacter pylori infection in healthy volunteers. Scand J Clin Lab Invest 2005; 65: 491-498.
52. Kopáčová M et al. Využití funkčních dechových testů v gastroenterologii. Hradec Králové: Nucleus HK 2006.
53. Kopáčová M, Bureš J, Koupil I et al. Body indices and basic vital signs in Helicobacter pylori positive and negative persons. Eur J Epidemiol 2007; 22: 67-75. (Pubitemid 46208248)
54. Šterzl I, Hrdá P, Matucha P et al. Anti-Helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res 2008; 57 (Suppl 1): S135-S141.
55. Fixa B, Komárková O, Nožička Z. Changing prevalence of some selected gastrointestinal diseases vis-à-vis H. pylori infection. Hepatogastroenterology 2011; 58: 1062-1066.
56. Fixa B, Komárková O, Melichar B et al. Výskyt infekce Helicobacter pylori u české dospělé populace. Čes Slov Gastroent 1995; 49: 83-85.
57. Mégraud F, Bouchard S, Brugmann D et al. Seroprevalence of Helicobacter pylori infection in six countries of eastern Europe using common methodology. Gut 1995; 37 (Suppl 1): A71.
58. Dítě P, Hep A, Dolina J et al. Prevalence infekce Helicobacter pylori v ČR - region jižní Morava. Vnitř Lék 1998; 44: 132-134.
59. 13C-urea breath test in 389 symptom-free persons. Gut 1999; 45 (Suppl 5): A106.
60. Bureš J, Kopáčová M, Rejchrt S. Pokles prevalence infekce Helicobacter pylori v České republice. Čas Lék Čes 2008; 147: 255-257.
61. Fixa B. Úvahy o poklesu prevalence infekce Helicobacter pylori a vředové choroby v posledních dvou dekádách. Čas Lék Čes 2011; 150: 91-93.
62. Jurgoš L. Infekcia Helicobacter pylori a funkčná dyspepsia - argumenty pre a proti. Postgrad Med (Praha) 2003; 5: 530-534.
63. Oona M, Utt M, Nilsson I et al. Helicobacter pylori infection in children in Estonia: decreasing seroprevalence during the 11-year period of profound socioeconomic changes. Helicobacter 2004; 9: 233-241. (Pubitemid 38724759)
64. Loffeld RJ, van der Putten AB. Changes in prevalence of Helicobacter pylori infection in two groups of patients undergoing endoscopy and living in the same region in the Netherlands. Scand J Gastroenterol 2003; 38: 938-941. (Pubitemid 37153621)
65. Roosendaal R, Kuipers EJ, Buitenwerf J et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rate in childhood. Am J Gastroent 1997; 92: 1480-1482. (Pubitemid 27412869)
66. Harvey RF, Spence RW, Lane JA et al. Relationship between the birth cohort pattern of Helicobacter pylori infection and the epidemiology of duodenal ulcer. Q J Med 2002; 95: 519-525. (Pubitemid 34919142)
67. Vyse AJ, Gay NJ, Hesketh LM et al. The burden of Helicobacter pylori infection in England and Wales. Epidemiol Infect 2002; 128: 411-417. (Pubitemid 34716369)
68. Rosenbacher D, Schultze V, Jähnig P et al. Evidence of a rapid decrease in prevalence of Helicobacter pylori infection in children of a high risk group living in Germany. Eur J Pediatr 2004; 163: 339-340. (Pubitemid 38725546)
69. Kosunen TU, Aromaa A, Knekt P et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997; 119: 29-34. (Pubitemid 27379390)
70. Rehnberg-Laiho L, Salomaa A, Rautelin H et al. Accelerated decline in Helicobacter pylori seroprevalence rate during the screen and treat project in Vammala, Finland, as demonstrated in 29- to 45-year-old pregnant women. Acta Pathol Microbiol Immunol Scand 2004; 112: 34-38. (Pubitemid 38297164)
71. Apostolopoulos P, Vafiadis-Zouboulis I, Tzivras M et al. Helicobacter pylori (H pylori) infection in Greece: the changing prevalence during a ten-year period and its antigenic profile. BMC Gastroenterology 2002; 2: 11.
72. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 2000; 22: 283-297. (Pubitemid 32116099)
73. O'Connor H, Sebastian S. The burden of Helicobacter pylori infection in Europe. Aliment Pharmacol Ther 2003; 18 (Suppl 3): 38-44. (Pubitemid 37357440)
74. Rautelin H, Kosunen TU. Helicobacter pylori infection in Finland. Ann Med 2004; 36: 82-88. (Pubitemid 38510014)
75. Guslandi M, Fanti L, Testoni PA. Helicobacter pylori seroprevalence in Crohn's disease: lack of influence by pharmacological treatment. Hepatogastroenterology 2002; 49: 1296-1297.
76. Prónai L, Schandl L, Orosz Z et al. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role. Helicobacter 2004; 9: 278-283. (Pubitemid 38724765)
77. Bateson MC. Cigarette smoking and Helicobacter pylori infection. Postgrad Med J 1993; 69: 41-44. (Pubitemid 23052768)
78. Brenner H, Rothenbacher D, Bode G et al. Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. Br Med J 1997; 315: 1489-1492. (Pubitemid 27517174)
79. Moayyedi P, Forman D, Braunholtz D et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Am J Gastroent 2000; 95: 1448-1455. (Pubitemid 30396301)
80. 13C-urea breath test in Helicobacter pylori positive persons with and without dyspepsia. Folia Gastroenterol Hepatol 2004; 2: 105-110.
81. Rejchrt S et al. Prevalence a sociodemografická Charakteristika dyspepsie v České republice. Hradec Králové: Nucleus HK 2005.
82. Rejchrt S, Koupil I, Kopáčová M et al. Prevalence and socio-demographic determinants of uninvestigated dyspepsia in the Czech Republic. Eur J Gastroenterol Hepatol 2008; 20: 898-905.
83. Sykora J, Hejda V, Varvarovská J et al. Helicobacter heilmannii gastroduodenal disease and clinical aspects in children with dyspeptic symptoms. Acta Paediatr 2004; 93: 707-709. (Pubitemid 38570243)
84. 13C-oktanovou kyselinou. Metodika testu pro dospělé a výsledky vyšetř ení zdravých dobrovolníků. Čas Lék Čes 2005; 144 (Suppl 3): 18-22.
85. 13C-octanoic acid breath test in healthy volunteers. Folia Gastroenterol Hepatol 2007; 5: 5-11.
86. Bures J, Kabelác K, Kopácová M et al. Electrogastrography in patients with Roux-en-Y reconstruction after previous Billroth gastrectomy. Hepatogastroenterology 2008; 55: 1492-1496.
87. Fock KM. Functional dyspepsia, H. pylori and post infectious FD. J Gastroenterol Hepatol 2011; 26 (Suppl 3): 39-41.
88. Maes BD, Ghoos YF, Hiele MI et al. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci 1997; 42: 1158-1162. (Pubitemid 27343439)
89. Quartero AO, de Wit NJ, Lodder AC et al. Disturbed solid-phase gastric emptying in functional dyspepsia. A meta-analysis. Dig Dis Sci 1998; 43: 2028-2033.
90. Longstreth GF. Functional dyspepsia. UpToDate. http://www.uptodate.com/ contents/functional-dyspepsia.
91. Bureš J, Rejchrt S, Vortel J et al. Ekonomické aspekty eradikace Helicobacter pylori u vředové choroby duodena. Remedia 1997; 7: 324-327.
92. Salih BA. Helicobacter pylori infection in developing countries: the burden for how long? Saudi J Gastroenterol 2009; 15: 201-207.
93. Lee SA, Kang D, Shim KN et al. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 2003; 13: 162-168. (Pubitemid 44143816)
94. Ki MR, Ghim SY, Hong IH et al. In vitro inhibition of Helicobacter pylori growth and of adherence of cagA-positive strains to gastric epithelial cells by Lactobacillus paraplantarum KNUC25 isolated from kimchi. Lactobacillus paraplantarum KNUC25. J Med Food 2010; 13: 629-634.
95. Lionetti E, Indrio F, Pavone Letal. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature. Helicobacter 2010; 15: 79-87.
96. Agarwal K, Agarwal S. Helicobacter pylori vaccine: from past to future. Mayo Clin Proc 2008; 83: 169-175. (Pubitemid 351303101)
97. Aebischer T, Meyer TF, Andersen LP. Inflammation, immunity, and vaccines for Helicobacter. Helicobacter 2010; 15 (Suppl 1): 21-28.
98. Blaser MJ. Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep 2006; 7: 956-960. (Pubitemid 44480504)
99. Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 2009; 119: 2475-2487.
100. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 2009; 136: 1863-1873.
101. Crowe SE. Pathophysiology of and immune response to Helicobacter pylori infection. UpToDate on line 19. 2. Wellesley, 2011. Available at: http://www.uptodate.com/contents/pathophysiology-of-and-immune-response-to- helicobacter-pylori-infection.
102. Crowe SE. Association between Helicobacter pylori infection and gastrointestinal malignancy. UpToDate on line 19. 2. Wellesley, 2011. Available at: http://www.uptodate.com/contents/association-between-helicobacter-pylori- infection-and-gastrointestinal-malignancy.